Welcome to our dedicated page for AMERIPRISE FINANCIAL SEC filings (Ticker: AMP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMERIPRISE FINANCIAL's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMERIPRISE FINANCIAL's regulatory disclosures and financial reporting.
Ameriprise Financial Inc. files a Form 13F reporting institutional holdings. The filing states a Form 13F Information Table entry total of 11,197 and a reported aggregate market value of $431,759,920,597. The submission lists 12 other included managers and provides standard cover-page attestations.
The report is a 13F Combination Report, indicating some holdings are reported here and some by other managers. The filing is a routine institutional holdings disclosure and does not by itself indicate trading intent or transaction details.
Ameriprise Financial, Inc. submitted a Form 144 notice relating to proposed sales of Common Stock tied to vesting of compensatory equity awards and the net exercise of non-qualified stock options.
The filing lists line items including 5,471 shares (vesting/compensatory award) and 784 shares (net exercise) and notes 89,897,084 shares outstanding as of 05/14/2026.
Ameriprise Financial director Robert Francis Sharpe Jr. reported an indirect open-market sale of 1,200 shares of common stock at $465.83 per share by a trust for a family member. After this transaction, that trust held 6,300 shares. Additional reported holdings were 3,625 shares held directly, 1,650 shares held by an irrevocable trust for a family member, and 202 shares held by his revocable trust.
State Street Corporation reports beneficial ownership of 4,595,792 shares (5.1%) of Ameriprise Financial, Inc. The filing states State Street has shared voting power of 730,391 shares and shared dispositive power of 4,592,587 shares as of 03/31/2026. The filing lists multiple State Street advisory subsidiaries as holders.
Ameriprise Financial, Inc. reported strong quarterly results for the three months ended March 31, 2026. Net income rose to $915 million from $583 million a year earlier, while total revenues increased to $4.886 billion from $4.481 billion, driven mainly by higher management, financial advice and distribution fees.
Basic earnings per share increased to $9.81, and diluted EPS to $9.68, up from $5.92 and $5.83. Total assets were $184.4 billion and total equity $6.2 billion. Operating cash flow was $459 million, and the company returned capital through $152 million of dividends and $886 million of share repurchases.
BRYAN GLYNIS reported acquisition or exercise transactions in this Form 4 filing.
Ameriprise Financial director Glynis Bryan reported a new grant of deferred compensation tied to company stock. She received 441.7518 phantom stock units at a stated price of $0.0000 per unit, increasing her phantom stock balance to 960.6152 units.
Each phantom stock unit represents the right to receive one share of Ameriprise Financial common stock. When she ceases to be a non-employee director, these deferred share units will be settled in common stock on a one-for-one basis, paid in a lump sum after the end of the quarter following her board service termination.
NEAL BLIXT DIANNE reported acquisition or exercise transactions in this Form 4 filing.
Ameriprise Financial director Dianne Neal Blixt received a grant of 441.7518 phantom stock units as compensation. Each phantom share represents the right to receive one share of Ameriprise Financial common stock. After this award, she holds a total of 13,122.6137 phantom stock units.
The phantom stock is deferred: when she ceases to be a non-employee director, her deferred share units will be settled in Ameriprise common stock on a one-for-one basis, paid in a lump sum at the end of the quarter following her departure from the board.
Sharpe Robert Francis JR reported acquisition or exercise transactions in this Form 4 filing.
AMERIPRISE FINANCIAL INC director Robert Francis Sharpe Jr. received a grant of 441.7518 shares of Phantom Stock (Annual) on April 29, 2026. Each phantom share represents the right to receive one share of Ameriprise common stock. Following this award, he holds a total of 40,092.3106 phantom stock units.
These deferred share units will be settled in Ameriprise common stock in a lump sum after he ceases to be a non-employee director, at the end of the quarter following his termination from the Board.
DiGeso Amy reported acquisition or exercise transactions in this Form 4 filing.
Ameriprise Financial director Amy DiGeso received a new phantom stock award as part of her board compensation. On this date, she was granted 441.7518 phantom stock units, each representing the right to receive one share of Ameriprise common stock. After this grant, she directly holds 13,122.6137 phantom stock units, which will be settled in Ameriprise common shares in a lump sum after her service as a non-employee director ends, following the quarter of her board departure.